Follow
Fanni Rencz
Title
Cited by
Cited by
Year
Alopecia areata and health‐related quality of life: a systematic review and meta‐analysis
F Rencz, L Gulácsi, M Péntek, N Wikonkál, P Baji, V Brodszky
British journal of dermatology 175 (3), 561-571, 2016
2212016
EQ-5D in central and Eastern Europe: 2000–2015
F Rencz, L Gulácsi, M Drummond, D Golicki, V Prevolnik Rupel, J Simon, ...
Quality of Life Research 25, 2693-2710, 2016
1362016
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ...
The European journal of health economics 15, 13-25, 2014
1092014
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
E Herédi, F Rencz, O Balogh, L Gulácsi, K Herszényi, P Holló, H Jókai, ...
The European Journal of Health Economics 15, 111-119, 2014
922014
A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia
V Brodszky, F Rencz, M Péntek, P Baji, PL Lakatos, L Gulácsi
Expert review of pharmacoeconomics & outcomes research 16 (1), 119-125, 2016
902016
Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe
F Rencz, M Péntek, M Bortlik, E Zagorowicz, T Hlavaty, A Śliwczyński, ...
World Journal of Gastroenterology: WJG 21 (6), 1728, 2015
832015
The rituximab biosimilar CT-P10 in rheumatology and cancer: a budget impact analysis in 28 European countries
L Gulácsi, V Brodszky, P Baji, F Rencz, M Péntek
Advances in therapy 34, 1128-1144, 2017
792017
Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary
F Rencz, V Brodszky, L Gulácsi, D Golicki, G Ruzsa, AS Pickard, EH Law, ...
Value in Health 23 (9), 1235-1245, 2020
742020
Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey
M Moradi, F Rencz, V Brodszky, A Moradi, O Balogh, L Gulácsi
Archives of Iranian medicine 18 (3), 0-0, 2015
672015
Psychometric properties of the Hungarian version of the eHealth Literacy Scale
Z Zrubka, O Hajdu, F Rencz, P Baji, L Gulácsi, M Péntek
The European Journal of Health Economics 20, 57-69, 2019
612019
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients
AK Poór, F Rencz, V Brodszky, L Gulácsi, Z Beretzky, B Hidvégi, P Holló, ...
Quality of Life Research 26, 3409-3419, 2017
592017
A detailed analysis of ‘not relevant’responses on the DLQI in psoriasis: potential biases in treatment decisions
F Rencz, AK Poór, M Péntek, P Holló, S Kárpáti, L Gulácsi, A Szegedi, ...
Journal of the European Academy of Dermatology and Venereology 32 (5), 783-790, 2018
582018
Use of biologics for psoriasis in Central and Eastern European countries
F Rencz, L Kemény, JZ Gajdácsi, W Owczarek, P Arenberger, GS Tiplica, ...
Journal of the European Academy of Dermatology and Venereology 29 (11), 2222 …, 2015
582015
Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis
F Rencz, L Gulácsi, M Péntek, AK Poór, M Sárdy, P Holló, A Szegedi, ...
British Journal of Dermatology 179 (5), 1102-1108, 2018
572018
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease
F Rencz, PL Lakatos, L Gulácsi, V Brodszky, Z Kürti, S Lovas, J Banai, ...
Quality of Life Research 28, 141-152, 2019
462019
Access to biologicals in Crohn’s disease in ten European countries
M Péntek, PL Lakatos, T Oorsprong, L Gulácsi, M Pavlova, W Groot, ...
World journal of gastroenterology 23 (34), 6294, 2017
442017
Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
F Rencz, B Tamási, V Brodszky, L Gulácsi, M Weszl, M Péntek
The European Journal of Health Economics 20, 43-55, 2019
432019
Is the DLQI appropriate for medical decision-making in psoriasis patients?
AK Poór, V Brodszky, M Péntek, L Gulácsi, G Ruzsa, B Hidvégi, P Holló, ...
Archives of Dermatological Research 310, 47-55, 2018
432018
Cost-of-illness studies in nine Central and Eastern European countries
V Brodszky, Z Beretzky, P Baji, F Rencz, M Péntek, A Rotar, K Tachkov, ...
The European Journal of Health Economics 20, 155-172, 2019
422019
Biosimilars for the management of inflammatory bowel diseases: economic considerations
L Gulacsi, M Pentek, F Rencz, V Brodszky, P Baji, Z Vegh, KB Gecse, ...
Current medicinal chemistry 26 (2), 259-269, 2019
422019
The system can't perform the operation now. Try again later.
Articles 1–20